感谢您下载白皮书《协同创新与保护:制药领域研发与知识产权之间的有效合作战略》。
本白皮书已发送至您的电子邮箱。如未收到,您可以点击下方按钮直接下载。

Latest from CAS Insights™

药物开发
How AI-driven analysis can accelerate drug discovery
Spiro[2.3]hexanes are an example of promising yet challenging scaffold structures for new drug compounds. By using AI-powered predictive analytics with CAS BioFinder, researchers more efficiently identified candidates for validation.

Digital R&D
Five Markers of AI Readiness in R&D
AI-powered solutions hold so much potential for faster scientific innovation, but there are key milestones organizations must achieve before they can move beyond the pilot phase. These five markers are the cornerstones of AI readiness.
.avif)
新兴科学
Point-of-care testing: faster diagnosis, easier access to care
Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.